Identification of a subnuclear body involved in sequence-specific cytokine RNA processing

Nature Communications

Volumn 6, Issue , 2015, Pages

  Lee, Sungwook ^a   Lee, Taeyun A ^a   Lee, Eunhye ^a   Kang, Sujin ^a   Park, Areum ^a   Kim, Seung Won ^b   Park, Hyo Jin ^a   Yoon, Je Hyun ^c   Ha, Sang Jun ^a   Park, Taesun ^a   Lee, Ju Seog ^d   Cheon, Jae Hee ^b   Park, Boyoun ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; TAR DNA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN; TDP-43 PROTEIN, MOUSE;

GENE EXPRESSION; IMMUNE RESPONSE; METABOLISM; PROTEIN; RNA; SERUM;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; BONE MARROW DERIVED MACROPHAGE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; COILED BODY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; INNATE IMMUNITY; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PROMYELOCYTIC LEUKEMIA; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METABOLISM; RNA PROCESSING; RNA SEQUENCE; RNA SPLICING; RNA STABILITY; UBIQUITINATION; ANIMAL; C57BL MOUSE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENETICS; INTRANUCLEAR SPACE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPLICEOSOME;

ANIMALS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, CELLULAR; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-10; INTERLEUKIN-6; INTRANUCLEAR SPACE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; SPLICEOSOMES; UBIQUITINATION;

EID: 84934450901     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6791     Document Type: Article

References (40)

1. Lamond, A. I. & Spector, D. L. Nuclear speckles: a model for nuclear organelles. Nat. Rev. Mol. Cell. Biol. 4, 605-612 (2003).
2. Handwerger, K. E. & Gall, J. G. Subnuclear organelles: new insights into form and function. Trends Cell Biol. 16, 19-26 (2006).
3. Matera, A. G., Izaguire-Sierra, M., Praveen, K. & Rajendra, T. K. Nuclear bodies: random aggregates of sticky proteins or crucibles of macromolecular assembly? Dev. Cell 17, 639-647 (2009).
4. Sleeman, J. E. & Lamond, A. I. Newly assembled snRNPs associate with coiled bodies before speckles, suggesting a nuclear snRNP maturation pathway. Curr. Biol. 9, 1065-1074 (1999).
5. Jady, B. E., et al. Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal body following import from the cytoplasm. EMBO J. 22, 1878-1888 (2003).
6. Dundr, M., et al. In vivo kinetics of Cajal body components. J. Cell Biol. 164, 831-842 (2004).
7. Venteicher, A. S., et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323, 644-648 (2009).
8. Gall, J. G. Cajal bodies: the first 100 years. Annu. Rev. Cell Dev. Biol. 16, 273-300 (2000).
9. Kaiser, T. E., Intine, R. V. & Dundr, M. De novo formation of a subnuclear body. Science 322, 1713-1717 (2008).
10. Cioce, M. & Lamond, A. I. Cajal bodies: a long history of discovery. Annu. Rev. Cell Dev. Biol. 21, 105-131 (2005).
11. Akira, S., Taga, T. & Kishimoto, T. Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1-78 (1993).
12. Bogdan, C., Vodovotz, Y. & Nathan, C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555 (1991).
13. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
14. Wellen, K. E. & Hotamisligil, G. S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788 (2003).
15. Ou, S. H., Wu, F., Harrich, D., Garcia-Martinez, L. F. & Gaynor, R. B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584-3596 (1995).
16. Sephton, C. F., et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 285, 6826-6834 (2010).
17. Chadt, A., et al. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat. Genet. 40, 1354-1359 (2008).
18. Chiang, P. M., et al. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl Acad. Sci. USA 107, 16320-16324 (2010).
19. Lagier-Tourenne, C., Polymenidou, M. & Cleveland, D. W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64 (2010).
20. Polymenidou, M., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459-468 (2011).
21. Tollervey, J. R., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452-458 (2011).
22. Neumann, M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 (2006).
23. Johnson, B. S., McCaffery, J. M., Lindquist, S. & Gitler, A. D. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 105, 6439-6444 (2008).
24. Xu, Y. F., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 30, 10851-10859 (2010).
25. Swarup, V., et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 208, 2429-2447 (2011).
26. Herman, A. M., Khandelwal, P. J., Rebeck, G. W. & Moussa, C. E. Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Exp. Neurol. 235, 297-305 (2012).
27. Janeway, Jr. C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
28. Cheng, Y. C., et al. F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression. J. Neurochem. 110, 947-955 (2009).
29. Pellizzoni, L., Yong, J. & Dreyfuss, G. Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775-1779 (2002).
30. Igaz, L. M., et al. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 284, 8516-8524 (2009).
31. Hans, F., et al. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J. Biol. Chem. 289, 19164-19179 (2014).
32. Stanek, D. & Neugebauer, K. M. The Cajal body: a meeting place for spliceosomal snRNPs in the nuclear maze. Chromosoma 115, 343-354 (2006).
33. Hebert, M. D. & Matera, A. G. Self-association of coilin reveals a common theme in nuclear body localization. Mol. Biol. Cell 11, 4159-4171 (2000).
34. Xu, H., et al. The C-terminal domain of coilin interacts with Sm proteins and U snRNPs. Chromosoma 114, 155-166 (2005).
35. Lemm, I., et al. Ongoing U snRNP biogenesis is required for the integrity of Cajal bodies. Mol. Biol. Cell 17, 3221-3231 (2006).
36. Sleeman, J. E., Ajuh, P. & Lamond, A. I. snRNP protein expression enhances the formation of Cajal bodies containing p80-coilin and SMN. J. Cell Sci. 114, 4407-4419 (2001).
37. Zhang, Y. J., et al. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534 (2007).
38. Park, B., et al. Granulin is a soluble cofactor for toll-like receptor 9 signaling. Immunity 34, 505-513 (2011).
39. Tanaka, A., et al. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Res. Ther. 14, R244 (2012).
40. Shalek, A. K., et al. Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature 510, 363-369 (2014).